Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Are Motivation Deficits Underestimated in Patients With ADHD? A Review of the LiteratureA critical appraisal of atomoxetine in the management of ADHDMethylphenidate use in children with attention deficit hyperactivity disorderDeveloping interventions for cancer-related cognitive dysfunction in childhood cancer survivorsMethylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trialsComparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials.Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescentsPractitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescentsFunctional consequences of attention-deficit hyperactivity disorder on children and their families.Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysis.A unique pattern of cortical connectivity characterizes patients with attention deficit disorders: a large electroencephalographic coherence study.Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidateAtomoxetine and stimulant medications in children and adolescents with persistent symptoms of attention deficit hyperactivity disorder despite monotherapy.Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategiesComparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysisEfficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.Psychopharmacology and psychotherapy for the treatment of adults with ADHD-a systematic review of available meta-analyses.Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to management.Attention-deficit hyperactivity disorder (ADHD): an updated review of the essential facts.Beyond symptom control for attention-deficit hyperactivity disorder (ADHD): what can parents do to improve outcomes?Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?Long-Term Efficacy of Methylphenidate Immediate-Release for the Treatment of Childhood ADHD.The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes.The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research.Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials.Neural Correlates of Symptom Improvement Following Stimulant Treatment in Adults with Attention-Deficit/Hyperactivity DisorderManaging the comorbidity of schizophrenia and ADHD.Updates on treatment of attention-deficit/hyperactivity disorder: facts, comments, and ethical considerations.The influence of paroxetine on the pharmacokinetics of atomoxetine and its main metabolite.Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorderRole of GIRK channels on the noradrenergic transmission in vivo: an electrophysiological and neurochemical study on GIRK2 mutant mice.
P2860
Q22061981-8CD47C6D-6EF3-4907-98DA-7D52338F5E79Q22241207-EB81D382-FF5C-4596-A386-69C780E1EBE4Q26771187-AFA9C515-E4B2-45E4-AD1C-3CBD2C5D5DE4Q26824793-A9A8F016-1CAB-4264-9E49-6708CF54CC17Q26825655-1F0D5AB0-4CA0-4B42-BABF-0E6CD85F3757Q27007856-6E2E94EF-601B-41B5-8FB5-065F8FC4A888Q27692676-18D65BD9-44AA-4A46-9630-7E86257DD516Q28265059-07EEC57F-D9FD-4D1D-903F-6E48E6F612C2Q28282770-DA00195D-53D0-4B27-A452-5DC66F140FA2Q30251626-52CC1060-1A70-42AF-BEC3-73DD771DFAF9Q30710211-775404AB-607F-471E-885A-863EA3EED027Q30988486-58E3EAFC-9808-4703-B0D4-1469B7E03309Q33165620-34DB95FD-8414-473F-96C4-32BF640CA3A1Q34459431-3BA8B9CA-38AF-4854-A3C6-E0E425ABB32BQ34650130-F2059DD6-3058-4AFA-834B-DED9CD6700E2Q35056233-CB3F072D-DB14-4DD5-BF1D-C925EB2737EBQ36301295-F79159EC-57D4-4A4B-8CE0-AC70BD4D611FQ36526984-45C2FA1A-892E-4B35-A0FB-7EA9199D1B70Q36595998-C8EB14DB-1BED-4D1C-B008-15AA6304A44AQ36740445-7C9E9FC5-F8D1-4091-B042-83FC742575D8Q36983210-47FB1080-17A3-4715-AF8A-5501F82F0041Q37330660-A4923313-E969-4D9E-AD99-D27DBB56023FQ37390217-71F5A029-9F3C-43E7-86FC-D7936191FA76Q37598192-E777FA03-3128-4C7E-AED4-3B40AE436B73Q38112253-FDABAAD7-4859-4950-9748-6006DEF532A5Q38176839-11CE477B-2C87-452B-96F7-7706546732EEQ38203939-3E4D4A34-F63B-4918-BE73-95A2E205ECF5Q38218624-734AEF21-A826-4C24-9815-8BF92D98D627Q38242438-D36AF61F-7FF0-4350-B31D-C967E5FE3573Q38287037-A5C7E5AE-CC48-4B4A-9CCD-7365057B707EQ38362252-F8C8489E-E49D-4C4A-ABA8-238FD8197276Q38537323-7AA980BA-D5F7-4458-8853-A47472BB60D7Q38862420-1C9A6517-2E5C-4E82-84E4-3CECA8928AC8Q39040595-97EEECD7-2D8E-464F-9ED5-A5A9C98D8634Q39878427-4AB55646-6B3F-4F22-A2EE-43EDEBC67756Q41000600-5838FB5D-FF78-4B66-8F2E-34A59AED639BQ41473870-20EA83AF-4CD4-432B-9B17-14F4C92A0AEFQ41870082-4C618DAF-21B4-4A4F-B49C-1334126CD4CBQ41874932-8E7C0BE5-EDCB-44E1-A0E0-CDB2725B4350Q42513774-A950C830-47A0-4B7D-9791-122A8EB7A988
P2860
Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparative efficacy and accep ...... adolescents: a meta-analysis.
@ast
Comparative efficacy and accep ...... adolescents: a meta-analysis.
@en
Comparative efficacy and accep ...... adolescents: a meta-analysis.
@nl
type
label
Comparative efficacy and accep ...... adolescents: a meta-analysis.
@ast
Comparative efficacy and accep ...... adolescents: a meta-analysis.
@en
Comparative efficacy and accep ...... adolescents: a meta-analysis.
@nl
prefLabel
Comparative efficacy and accep ...... adolescents: a meta-analysis.
@ast
Comparative efficacy and accep ...... adolescents: a meta-analysis.
@en
Comparative efficacy and accep ...... adolescents: a meta-analysis.
@nl
P2093
P2860
P921
P356
P1433
P1476
Comparative efficacy and accep ...... adolescents: a meta-analysis.
@en
P2093
Madhri Senanayake
Raveen Hanwella
Varuni de Silva
P2860
P2888
P356
10.1186/1471-244X-11-176
P577
2011-11-10T00:00:00Z
P5875
P6179
1018218816